TAKE Controlsp. z o.o.

Out-of-school forms of sports and leisure education

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2017-03-08
Share capital
5,000.00 PLN
Registered address
os. Stefana Batorego 73/49, 60-687 Poznań, Poland

Financials

Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.

Revenue history (in k)

Filing timeliness

No financial statement for 2024 – the filing deadline has passed. 5 of 6 financial statements were filed late (the longest delay 484 days for 2018).

  • 2024not filed
  • 202316/09/2024
  • 202216/09/2024
  • 202114/06/2022
  • 202010/06/2022
  • 201924/11/2020
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Trademarks

TAKE Control holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2019.

MarkNumberClassesStatusProtected until
Take Control #przejmijkontrole(word)Z.50346541Protected Aug 14, 2029
MarkProtected until
Take Control #przejmijkontrole(word)Aug 14, 2029

Authorized Representatives

Bartłomiej Marek Czarneckiage 34 – Management Board Member
Leszek Janusz Oleksyage 42 – Management Board Member

Manner of representation

If a multi-member management board is appointed, joint action by two members of the management board is required to make declarations and sign on behalf of the company.

Ownership

OwnerSharesShare valueStake
50$675.3150%
50$675.3150%

Beneficial owners

Person

Debt

No entries in the National Debtors Register (KRZ).

Public aid

5 public aid cases recorded, with a total value of $6,457.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,294
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,294
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,294

Competitors

FAQ

Last updated: 2026-04-22